Insider Trading History of Huang Jane


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Huang Jane since year 2005. The trader's CIK number is 1683913. At the time of the last reporting, Huang Jane was the CMO, Hematology of Beigene, Ltd. . (stock ticker symbol BGNE). See this page for all insider trading activities at Beigene, Ltd. .


Stock purchases, sales, and option exercises reported by insider Huang Jane since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2019-09-04 BGNE Beigene, Ltd. Sale 82 129.40 10,610
2019-09-03 BGNE Beigene, Ltd. Sale 2,862 144.68 414,062
2019-08-12 BGNE Beigene, Ltd. Option Ex 2,500 45.31 113,275
2019-08-12 BGNE Beigene, Ltd. Sale 2,500 134.90 337,237
2019-07-29 BGNE Beigene, Ltd. Option Ex 10,130 37.40 378,862
2019-07-29 BGNE Beigene, Ltd. Sale 10,130 133.97 1,357,075
2019-06-27 BGNE Beigene, Ltd. Sale 430 125.42 53,929
2019-05-20 BGNE Beigene, Ltd. Option Ex 300 45.31 13,593
2019-05-21 BGNE Beigene, Ltd. Option Ex 2,200 45.31 99,682
2019-05-20 BGNE Beigene, Ltd. Sale 300 130.12 39,036
2019-05-21 BGNE Beigene, Ltd. Sale 2,200 130.06 286,132
2019-04-08 BGNE Beigene, Ltd. Sale 14,130 143.26 2,024,306
2019-04-08 BGNE Beigene, Ltd. Option Ex 14,130 29.49 416,693
2019-03-07 BGNE Beigene, Ltd. Sale 71 140.50 9,975
2019-03-11 BGNE Beigene, Ltd. Option Ex 2,565 29.49 75,641
2019-03-11 BGNE Beigene, Ltd. Sale 2,565 130.00 333,450
2018-11-26 BGNE Beigene, Ltd. Option Ex 3,000 29.49 88,470
2018-11-26 BGNE Beigene, Ltd. Sale 3,000 139.58 418,749
2018-09-04 BGNE Beigene, Ltd. Sale 2,911 174.59 508,246
2017-12-21 BGNE Beigene, Ltd. Sale 1,000 98.00 98,000
2017-12-21 BGNE Beigene, Ltd. Option Ex 1,000 29.51 29,510
2017-12-13 BGNE Beigene, Ltd. Option Ex 1,500 29.51 44,265
2017-12-13 BGNE Beigene, Ltd. Sale 1,500 94.37 141,556
2017-12-04 BGNE Beigene, Ltd. Sale 1,100 86.00 94,600
2017-11-20 BGNE Beigene, Ltd. Sale 1,000 87.00 87,000
2017-11-16 BGNE Beigene, Ltd. Sale 600 85.00 51,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Huang Jane (CMO, Hematology of Beigene, Ltd. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month